Overview
Emily Vasiljevski practices in Sydney, Australia. Ms. Vasiljevski is rated as an Advanced expert by MediFind in the treatment of Neurofibromatosis. Her top areas of expertise are Primary Carnitine Deficiency, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Cardiomyopathy.
Her clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Neurofibromatosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Primary Carnitine DeficiencyMs. Vasiljevski isDistinguished. Learn about Primary Carnitine Deficiency.
- Advanced
- NeurofibromatosisMs. Vasiljevski isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Ms. Vasiljevski isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- Experienced
- CardiomyopathyMs. Vasiljevski isExperienced. Learn about Cardiomyopathy.